about
The Nucleotide Oligomerization Domain-Like Receptors in Kidney InjuryActivation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome.IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline.Maresin 1 Mitigates High Glucose-Induced Mouse Glomerular Mesangial Cell Injury by Inhibiting Inflammation and FibrosisThe role of the complement system in diabetic nephropathy.Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathwaysAldose reductase mediates retinal microglia activation.A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammation.Association of Pentraxin 3 Gene Polymorphisms with Susceptibility to Diabetic Nephropathy.Inflammasomes in the urinary tract: a disease-based review.Targeting inflammation in diabetic kidney disease: early clinical trials.Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.MicroRNA-146a-5p Mediates High Glucose-Induced Endothelial Inflammation via Targeting Interleukin-1 Receptor-Associated Kinase 1 Expression.Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Müller Cells of Diabetic Human and Rodent RetinaA molecular morphometric approach to diabetic kidney disease can link structure to function and outcome.Epigenetics in diabetic nephropathy, immunity and metabolism.Role of MAIT cells in the immunopathogenesis of inflammatory diseases: New players in old game.Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases.Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy.Recent progress in the use and tracking of transplanted islets as a personalized treatment for type 1 diabetes.Gene Expression Profiling Identifies Downregulation of the Neurotrophin-MAPK Signaling Pathway in Female Diabetic Peripheral Neuropathy Patients.Systemic inflammation in acute intermittent porphyria: a case-control study.Astilbin Inhibits High Glucose-Induced Inflammation and Extracellular Matrix Accumulation by Suppressing the TLR4/MyD88/NF-κB Pathway in Rat Glomerular Mesangial Cells
P2860
Q26740429-1B148B98-52D4-459F-92B3-2DF1962B6C52Q27303195-257AB7D7-2831-4CED-985D-D32E5DDAEB06Q27315329-5995A7A6-F092-4061-B75C-B98751D7225CQ29248428-5C52453D-CC3F-40EC-8AAD-B9CD8D0112B9Q30235417-2414298E-6942-45D8-A6CD-DBFC21341178Q33720208-3C7FB6C8-A7E1-439D-BEF9-80A72E0FB3A9Q36813604-E608C8B9-287C-425B-B061-D1B6C7C25B2FQ36903131-71DD4777-9528-4F79-88DA-EEC0F969D80DQ37621173-A03CF168-085B-4BF5-BD95-FCFC1B43FE41Q38832656-951062C2-CBA5-435C-A64A-13A1A79D5DC9Q38857166-037BEC06-ED8C-475C-AF60-06403149B8FDQ39445103-49E22728-2E98-4CE2-9E7A-A2615C908CABQ41204092-BB14F372-FE33-411F-82C8-AEB9178BB844Q41335256-A38780B9-3CF2-4750-9875-42B33F97F9DEQ42372999-2A7997CF-153D-4DCF-8EF3-5ED3A4D5C362Q45972129-CDDE0730-3844-43B9-A6B0-5791F57FB56DQ47412518-752DA18E-E687-4A31-AA60-060F2EEC4426Q47589231-91D9F727-FEB0-4190-99D8-69F1131680ECQ47682969-9A909E17-5CBD-4259-B61A-CAFEA6DB032FQ47769540-9C9FE410-2ACE-4DF0-9ECE-DD2D86717FF4Q48510837-9D98F3A8-9684-49EB-BE5F-28AC7D6FB048Q49480228-5AF293E6-8F86-4EE0-81C1-848A39213951Q51320785-CE963C7A-5490-411B-92A9-BD555A0B5976Q59136320-6741C62D-8BA9-4B2F-8E15-6F1B3C072123
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Innate immunity in diabetes and diabetic nephropathy.
@en
type
label
Innate immunity in diabetes and diabetic nephropathy.
@en
prefLabel
Innate immunity in diabetes and diabetic nephropathy.
@en
P2860
P356
P1476
Innate immunity in diabetes and diabetic nephropathy.
@en
P2093
Hirofumi Makino
P2860
P2888
P356
10.1038/NRNEPH.2015.175
P407
P50
P577
2015-11-16T00:00:00Z